Ann: Virtual Investor Briefing for Quarterly Reports, page-7

Hang in there. Early days for this company yet (even the 'sophisticated investors' who bought @ 0.26 in the recent raising are down a fair bit - I'm sure Jason's already receiving some WTF phone calls and emails from them). Seriously though, it needs more time to see whether it will be successful or not.
What I'm really interested in over the next 12 months is whether or not one of the larger trial sites makes a repeat order / expanded order going forward. That for me would be a signal (either positive or negative) of people who have trialed the product and decided they either can / can't live without it. If none of the trial sites renew orders / expand orders I would be less confident.